DE59905829D1 - NEW NAPHTHYL AND ANILIDE SUBSTITUTED SULPHONAMID - Google Patents

NEW NAPHTHYL AND ANILIDE SUBSTITUTED SULPHONAMID

Info

Publication number
DE59905829D1
DE59905829D1 DE59905829T DE59905829T DE59905829D1 DE 59905829 D1 DE59905829 D1 DE 59905829D1 DE 59905829 T DE59905829 T DE 59905829T DE 59905829 T DE59905829 T DE 59905829T DE 59905829 D1 DE59905829 D1 DE 59905829D1
Authority
DE
Germany
Prior art keywords
sulphonamid
anilide
substituted
naphthyl
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE59905829T
Other languages
German (de)
Inventor
Wolfgang Bender
Juergen Reefschlaeger
Peter Eckenberg
Siegfried Goldmann
Michael Haerter
Sabine Hallenberger
Joerg Trappe
Olaf Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of DE59905829D1 publication Critical patent/DE59905829D1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46Y being a hydrogen or a carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE59905829T 1998-01-23 1999-01-09 NEW NAPHTHYL AND ANILIDE SUBSTITUTED SULPHONAMID Expired - Fee Related DE59905829D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802439 1998-01-23
PCT/EP1999/000099 WO1999037609A1 (en) 1998-01-23 1999-01-09 Novel naphthyl-substituted and anilide-substituted sulfonamides

Publications (1)

Publication Number Publication Date
DE59905829D1 true DE59905829D1 (en) 2003-07-10

Family

ID=7855411

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59905829T Expired - Fee Related DE59905829D1 (en) 1998-01-23 1999-01-09 NEW NAPHTHYL AND ANILIDE SUBSTITUTED SULPHONAMID

Country Status (30)

Country Link
US (1) US6417181B1 (en)
EP (1) EP1049666B1 (en)
JP (1) JP2002501043A (en)
KR (1) KR20010034321A (en)
CN (1) CN1294578A (en)
AR (1) AR016978A1 (en)
AT (1) ATE242207T1 (en)
AU (1) AU2420799A (en)
BG (1) BG104617A (en)
BR (1) BR9907738A (en)
CA (1) CA2318182A1 (en)
CO (1) CO4810231A1 (en)
DE (1) DE59905829D1 (en)
EE (1) EE200000432A (en)
ES (1) ES2201666T3 (en)
GT (1) GT199900010A (en)
HR (1) HRP20000532A2 (en)
HU (1) HUP0200918A2 (en)
ID (1) ID25448A (en)
IL (1) IL137159A0 (en)
NO (1) NO20003601L (en)
NZ (1) NZ505900A (en)
PE (1) PE20000181A1 (en)
PL (1) PL341815A1 (en)
SK (1) SK11012000A3 (en)
SV (1) SV1999000006A (en)
TR (1) TR200002140T2 (en)
TW (1) TW461880B (en)
WO (1) WO1999037609A1 (en)
ZA (1) ZA99473B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919793A1 (en) 1999-04-30 2000-11-02 Bayer Ag New sulfonamides
DE19920790A1 (en) * 1999-05-06 2000-11-09 Bayer Ag Bis-sulfonamides with anti-HCMV activity
DE19934295A1 (en) * 1999-07-21 2001-01-25 Bayer Ag New thermodynamically stable crystal modification III of N-phenyl-naphthalene-sulfonamide derivative, is an antiviral agent especially useful for treating cytomegalovirus infections
DE19934321A1 (en) * 1999-07-21 2001-01-25 Bayer Ag New N-phenyl-naphthalenesulfonamide derivatives are antiviral agents especially useful for treating cytomegalovirus infections
WO2003007931A1 (en) * 2001-06-08 2003-01-30 Institute Of Medicinal Molecular Design. Inc. Sulfonamide derivatives
AU2003231370A1 (en) * 2002-04-18 2003-10-27 Institute Of Medicinal Molecular Design. Inc. Amide derivatives
WO2004058709A1 (en) 2002-12-23 2004-07-15 Millennium Pharmaceuticals, Inc. Ccr8 inhibitors
US7491827B2 (en) * 2002-12-23 2009-02-17 Millennium Pharmaceuticals, Inc. Aryl sulfonamides useful as inhibitors of chemokine receptor activity
TW200510311A (en) * 2002-12-23 2005-03-16 Millennium Pharm Inc CCr8 inhibitors
US7425527B2 (en) * 2004-06-04 2008-09-16 The Procter & Gamble Company Organic activator
RU2452490C1 (en) 2010-12-27 2012-06-10 Виктор Вениаминович Тец Drug with herpes virus family activity
JP2015520144A (en) 2012-05-11 2015-07-16 アクロン・モレキュールズ・アクチェンゲゼルシャフトAkron Molecules Ag Use of compounds for the treatment of pain
RU2530587C1 (en) 2013-06-07 2014-10-10 Виктор Вениаминович Тец Method of treating skin and mucosal diseases caused by herpes simplex viruses type 1 and type 2
RU2605602C1 (en) 2015-09-15 2016-12-27 Общество с ограниченной ответственностью "Новые Антибиотики" Method of producing sodium salt of (2,6-dichlorophenyl)amide carbopentoxysulphanilic acid
CN112062901B (en) * 2020-08-14 2023-03-21 合肥工业大学 Spiral fluorescent isonitrile copolymer and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2423572A (en) * 1946-05-03 1947-07-08 Du Pont Naphtholsulfonamidobenzaldehydes and acetals thereof
US2949479A (en) * 1954-06-17 1960-08-16 Dainippon Pharmaceutical Co Acyl derivatives of aminonaphthalene-sulfonamide
US3925347A (en) 1967-07-24 1975-12-09 Polaroid Corp Processes of synthesizing azo compounds
US3482971A (en) 1967-07-24 1969-12-09 Polaroid Corp Scavengers for oxidized developing agent
US4035401A (en) 1970-03-30 1977-07-12 Polaroid Corporation Intermediates for photographic dyes
JPS5499433A (en) 1978-01-20 1979-08-06 Konishiroku Photo Ind Co Ltd Dye image formation method
DE3863375D1 (en) 1987-03-19 1991-08-01 Agfa Gevaert Nv ORGANIC COMPOUNDS FOR THE DYE DIFFUSION TRANSFER METHOD AND PHOTOGRAPHIC ELEMENTS CONTAINING THESE COMPOUNDS.
EP0462179A4 (en) 1989-02-27 1992-03-18 The Du Pont Merck Pharmaceutical Company Novel sulfonamides as radiosensitizers
DE4331134A1 (en) 1993-09-14 1995-03-16 Bayer Ag New antiviral pseudopeptides
EP0684515A1 (en) 1994-05-27 1995-11-29 Eastman Kodak Company Photographic element and process incorporating a high dye-yield image coupler providing improved granularity

Also Published As

Publication number Publication date
AR016978A1 (en) 2001-08-01
WO1999037609A1 (en) 1999-07-29
IL137159A0 (en) 2001-07-24
CA2318182A1 (en) 1999-07-29
BG104617A (en) 2001-04-30
CN1294578A (en) 2001-05-09
PL341815A1 (en) 2001-05-07
HUP0200918A2 (en) 2002-09-28
EP1049666A1 (en) 2000-11-08
CO4810231A1 (en) 1999-06-30
TR200002140T2 (en) 2000-12-21
NO20003601D0 (en) 2000-07-13
ZA99473B (en) 1999-07-27
SK11012000A3 (en) 2001-01-18
ES2201666T3 (en) 2004-03-16
US6417181B1 (en) 2002-07-09
TW461880B (en) 2001-11-01
HRP20000532A2 (en) 2001-02-28
AU2420799A (en) 1999-08-09
JP2002501043A (en) 2002-01-15
PE20000181A1 (en) 2000-04-12
NO20003601L (en) 2000-09-14
ID25448A (en) 2000-10-05
EP1049666B1 (en) 2003-06-04
KR20010034321A (en) 2001-04-25
NZ505900A (en) 2002-02-01
EE200000432A (en) 2001-12-17
SV1999000006A (en) 2000-10-09
ATE242207T1 (en) 2003-06-15
BR9907738A (en) 2000-10-17
GT199900010A (en) 2000-07-15

Similar Documents

Publication Publication Date Title
PT1127052E (en) SUBSTITUTED 2-PHENYLBENZIMIDAZIDES ITS PREPARATION AND APPLICATION
DE69827984D1 (en) sulfonamide
ID23575A (en) PIRAZOLOPIRIMIDINA-PIRAZOLOPIRIMIDINA AND PIRAZOLOTRIAZINA-PIRAZOLOTRIAZINA
NO991944L (en) New connection
NO20004949D0 (en) sulfonamide
DE59905829D1 (en) NEW NAPHTHYL AND ANILIDE SUBSTITUTED SULPHONAMID
NO20003996D0 (en) New connection
DE69917983D1 (en) pin
NO993298D0 (en) New procedure
DE59914136D1 (en) dowel
DE69916694D1 (en) 2-hydroxy-5-methyl-hexan-3-one and 3-hydroxy-5-methyl-hexan-2-one
DE69905001T2 (en) coagulation
ID23258A (en) WITHDRAWAL-DELIVERY AND METHODS
NO995796D0 (en) New procedure
ATE210661T1 (en) NEW TETRAHYDROIOSOQUINOLINE THIOPHENECARBOXIMIDAMIDES
DE69925271D1 (en) ANGIOSTATIN-BINDING PROTEIN
DE59804489D1 (en) dowel
DK1141559T3 (en) dowel
DE59808611D1 (en) dowel
DE29802122U1 (en) Pushrod
DE29801860U1 (en) Electromagnet
DK199900299U3 (en) Dowel
DE59909202D1 (en) SIREN
FR2773770B1 (en) ANCHOR
FI972010A0 (en) Arrangements and arrangements

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BAYER HEALTHCARE AG, 51373 LEVERKUSEN, DE

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee